Founders Financial Securities’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $695K | Buy |
18,087
+760
| +4% | +$29.2K | 0.05% | 288 |
|
|
2025
Q1 | $659K | Sell |
17,327
-159
| -0.9% | -$6.05K | 0.06% | 277 |
|
|
2024
Q4 | $591K | Buy |
17,486
+513
| +3% | +$17.4K | 0.05% | 267 |
|
|
2024
Q3 | $694K | Sell |
16,973
-787
| -4% | -$32.2K | 0.06% | 223 |
|
|
2024
Q2 | $684K | Buy |
17,760
+542
| +3% | +$20.9K | 0.06% | 233 |
|
|
2024
Q1 | $738K | Buy |
+17,218
| New | +$738K | 0.08% | 206 |
|
|
2020
Q4 | – | Sell |
-11,370
| Closed | -$535K | – | 233 |
|
|
2020
Q3 | $535K | Sell |
11,370
-1,544
| -12% | -$72.7K | 0.17% | 88 |
|
|
2020
Q2 | $658K | Buy |
12,914
+891
| +7% | +$45.4K | 0.21% | 83 |
|
|
2020
Q1 | $569K | Sell |
12,023
-288
| -2% | -$13.6K | 0.21% | 66 |
|
|
2019
Q4 | $723K | Buy |
12,311
+38
| +0.3% | +$2.23K | 0.24% | 64 |
|
|
2019
Q3 | $655K | Buy |
12,273
+739
| +6% | +$39.4K | 0.21% | 78 |
|
|
2019
Q2 | $577K | Sell |
11,534
-2,064
| -15% | -$103K | 0.19% | 75 |
|
|
2019
Q1 | $710K | Sell |
13,598
-287
| -2% | -$15K | 0.23% | 72 |
|
|
2018
Q4 | $663K | Sell |
13,885
-665
| -5% | -$31.8K | 0.24% | 64 |
|
|
2018
Q3 | $731K | Sell |
14,550
-18
| -0.1% | -$904 | 0.2% | 70 |
|
|
2018
Q2 | $734K | Sell |
14,568
-267
| -2% | -$13.5K | 0.23% | 62 |
|
|
2018
Q1 | $725K | Buy |
14,835
+292
| +2% | +$14.3K | 0.23% | 62 |
|
|
2017
Q4 | $645K | Buy |
+14,543
| New | +$645K | 0.21% | 69 |
|
|
2017
Q1 | – | Sell |
-13,954
| Closed | -$672K | – | 103 |
|
|
2016
Q4 | $672K | Sell |
13,954
-16
| -0.1% | -$771 | 0.28% | 45 |
|
|
2016
Q3 | $753K | Sell |
13,970
-54,374
| -80% | -$2.93M | 0.32% | 47 |
|
|
2016
Q2 | $3.7M | Sell |
68,344
-382
| -0.6% | -$20.7K | 1.7% | 19 |
|
|
2016
Q1 | $3.48M | Buy |
+68,726
| New | +$3.48M | 1.64% | 18 |
|
|
2014
Q2 | – | Sell |
-25,339
| Closed | -$1.69K | – | 79 |
|
|
2014
Q1 | $1.69K | Buy |
25,339
+4,679
| +23% | +$312 | 1.13% | 24 |
|
|
2013
Q4 | $1.38M | Buy |
+20,660
| New | +$1.38M | 1.16% | 18 |
|